Receptor conversion in distant breast cancer metastases

INTRODUCTION: When breast cancer patients develop distant metastases, the choice of systemic treatment is usually based on tissue characteristics of the primary tumor as determined by immunohistochemistry (IHC) and/or molecular analysis. Several previous studies have shown that the immunophenotype o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoefnagel, Laurien DC, van de Vijver, Marc J, van Slooten, Henk-Jan, Wesseling, Pieter, Wesseling, Jelle, Westenend, Pieter J, Bart, Joost, Seldenrijk, Cornelis A, Nagtegaal, Iris D, Oudejans, Joost, van der Valk, Paul, van der Groep, Petra, de Vries, Elisabeth GE, van der Wall, Elsken, van Diest, Paul J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096964/
https://www.ncbi.nlm.nih.gov/pubmed/20863372
http://dx.doi.org/10.1186/bcr2645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096964/
https://www.ncbi.nlm.nih.gov/pubmed/20863372
http://dx.doi.org/10.1186/bcr2645

Ejemplares similares